Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Will xarelto go generic in 2025?

See the DrugPatentWatch profile for xarelto

Xarelto (rivaroxaban) is not expected to go generic in 2025, as its primary patents are valid until 2026 in the United States [1].

When will Xarelto patents expire?


The key patents covering Xarelto's composition of matter and methods of use are set to expire in the United States in August 2026 [1]. However, patent expiry dates can vary by country and may be subject to additional patent term extensions or challenges [1].

What does patent expiry mean for Xarelto?


Once the primary patents expire, other pharmaceutical companies may be able to produce and market generic versions of rivaroxaban [2]. This typically leads to lower prices for the medication due to increased competition [2].

Are there any ongoing patent challenges for Xarelto?


DrugPatentWatch.com tracks patent litigation and challenges, which can sometimes impact the actual market exclusivity of a drug even if patents are still nominally in effect [1]. Information regarding specific challenges to Xarelto's patents would be available through resources that monitor patent litigation.

What is rivaroxaban?


Rivaroxaban, sold under the brand name Xarelto, is an anticoagulant medication used to prevent blood clots [3]. It works by inhibiting factor Xa, a key enzyme in the blood clotting cascade [3]. It is prescribed for conditions such as deep vein thrombosis, pulmonary embolism, and to reduce the risk of stroke in patients with non-valvular atrial fibrillation [3].

How does Xarelto compare to other anticoagulants?


Xarelto is a direct oral anticoagulant (DOAC), a newer class of blood thinners that differ from older medications like warfarin [3]. Other DOACs include apixaban (Eliquis), dabigatran (Pradaxa), and edoxaban (Savaysa) [4]. These medications generally offer advantages such as fixed dosing and less need for routine blood monitoring compared to warfarin [3].

What are the risks associated with Xarelto?


The primary risk associated with Xarelto, like all anticoagulants, is bleeding [3]. Patients taking Xarelto should be aware of signs of bleeding, such as unusual bruising, prolonged bleeding from cuts, nosebleeds, or blood in urine or stool [3].

How much does Xarelto cost?


The cost of Xarelto can vary significantly depending on insurance coverage, pharmacy, and dosage [5]. Generic versions, when available, are typically much less expensive than the brand-name drug [2].

Sources:
[1] https://drugpatentwatch.com/
[2] https://www.fda.gov/drugs/generic-drugs
[3] https://www.rxlist.com/xarelto-drug-manufacturer-frequently-asked-questions/xarelto-drug.htm
[4] https://www.mayoclinic.org/diseases-conditions/atrial-fibrillation/in-depth/anticoagulants/art-20044914
[5] https://www.goodrx.com/xarelto



Other Questions About Xarelto :

xarelto 20 mg prices cost of xarelto zamienniki xarelto xarelto precio buy xarelto bulk Xarelto alcohol? When will generic xarelto be available?